infliximab : Related Words Words similar in meaning to infliximab
- infliximab«
- monoclonal antibody«
- disorder«
- patient«
- chimeric«
- crohn«
- monoclonal«
- autoimmune«
- disease«
- anti-TNF compound«
- etanercept«
- rheumatoid arthritis«
- receptor«
- drug«
- fistula«
- ulcerative colitis«
- adalimumab«
- psoriatic arthritis«
- immunosuppressant«
- treatment«
- remission«
- methotrexate«
- psoriasis«
- efficacy«
- inflectra«
- antibody«
- spondylitis«
- remsima«
- fda«
- tnf antagonist«
- centocor ortho biotech«
- tnf antibody«
- celltrion«
- janssen biotech«
- bowel«
- centocor«
- placebo treatment«
- disease treatment«
- behçet«
- clinical trial«
- grade a«
- fda approval«
- week«
- mouse«
- reactivation«
- psa«
- subclass«
- placebo«
- closure«
- xian janssen«
- william sandborn«
- transmembrane-«
- trade name remicade«
- tnf-α. etanercept«
- tnf-α. biological activity«
- tnf beta«
- th2 disease«
- sporadic therapy«
- similar immune cell«
- similar human antibody domain«
- respective product labeling«
- remicade®«
- remicade/infliximab«
- psoriasiform skin lesion«
- paul rutgeerts«
- onset vitiligo«
- mouse igg monoclonal antibody«
- mouse heavy«
- mouse common domain«
- lymphotoxin α«
- light chain constant region«
- lethal hepatosplenic t«
- infliximab target tnf«
- infliximab biosimilars«
- inflammatory skin condition disease«
- inflammatory crohn«
- infimab«
- human tnf-α«
- human antibody amino acid sequence«
- flixabi«
- fistula response«
- fda product labeling«
- extracellular-«
- epirus biopharmaceuticals«
- drug payment scheme«
- disease quiescence«
- concomitant immunosuppressant«
- chronic severe plaque psoriasis«
- chimeric monoclonal antibody biologic drug«
- cdai score«
- bow015«
- biosimilar infliximab«
- availability/affordability«
- antibody constant region«
- acute ulcerative colitis treatment trial«
- active axial involvement«
- blood vessel«
- adverse effect«
- tumor necrosis factor blocker«
- severe active crohn«
- other monoclonal antibody«
- loading regimen«
- light chain variable region«
- interleukin il-1«
- european medicine agency ’s«
- celltrion healthcare«
- authorization approval«
- antifolate drug«
- receptor fusion protein«
- placebo medication«
- infusion treatment«
- accent«
- nail psoriasis«
- major medical insurance«
- leukocyte movement«
- effective binding«
- centocor biotech«
- biosimilars«
- japan«
- tnf drug«
- severe flare«
- several therapy«
- level 1b«
- level 1a«
- jan vilcek«
- artificial antibody«
- inc.«
- th1 cytokine«
- placebo therapy«
- affinity«
- tnf agent«
- experimental mouse«
- modest efficacy«
- traditional agent«
- biosimilar«
- likelihood«
- transgenic animal model«
- principle study«
- dactylitis«
- certolizumab pegol«
- biosimilar version«
- form«
- medical insurance plan«
- initial dos«
- enthesitis«
- endothelial layer«
- multicentre trial«
- mouse antibody«
- differential action«
- act2«
- mitsubishi tanabe pharma«
- expensive medication«
- steroid medication«
- serum half«
- chimeric monoclonal antibody«
- eu«
- george kollias«
- infection«
- tnf inhibitor«
- humira«
- hospira«
- enbrel«
- remicade«
- polychondritis«
- potential patient«
- disease onset«
- abnormal connection«
- medical card«
- prescription drug coverage«
- nervous system disorder«
- symptom«
- biological therapy«
- indication«
- combination treatment«
- autoimmune reaction«
- tumor necrosis factor alpha«
- maintenance therapy«
- warning«
- marketing authorization«
- office setting«
- identical structure«
- biogen«
- chemical messenger«
- result«
- week interval«
- psa.«
- pancytopenia«
- capability«
- proinflammatory cytokine«
- johnson«
- cyclosporine«
- inadequate response«
- adhesion molecule«
- leukopenia«
- recombinant dna«
- intravenous infusion«
- human use«
- conventional treatment«
- immune reaction«
- azathioprine«
- final trial«
- monotherapy«
- inflammatory process«
- quality data«
- fusion protein«
- il-6«
- transmembrane«
- approval«
- transgenic mouse«
- gastroenterologist«
- cell«
- positive opinion«
- combination therapy«
- schering«
- medicinal product«
- soluble«
- neutropenia«
- u fda«
- outer membrane«
- cell lymphoma«
- phase«
- inflammatory disease«
- six-«
- biological agent«
- leflunomide«
- Remicade«
- 94-patient«
- 296-patient«
- Enbrel«
- Arava«
Sharpen your Skills with the Masters
The Only Grammar Book You'll Ever Need: A One-Stop Source for Every Writing Assignment
Rise of the Rocket Girls: The Women Who Propelled Us, from Missiles to the Moon to Mars
Steal Like an Artist: 10 Things Nobody Told You About Being Creative
The War of Art: Break Through the Blocks and Win Your Inner Creative Battles